Accordant Advisory Group Inc

Position in BMY — Bristol Myers Squibb Co

CIK 2013499 ANNAPOLIS, MD

Position in BMY

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$56,467

-$2,970 QoQ

Shares Held

980

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#2,310

of 2,506 holders

Holding Since

Mar 2024

10 quarters on record

Healthcare · as of Jun 30, 2026

Accordant Advisory Group Inc holds $832,855 across 7 Drug Manufacturers - General names. BMY ranks #5 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	2,031	$515,813
2	GILD	Gilead Sciences, Inc.	875	$110,547
3	MRK	Merck & Co., Inc.	563	$72,345
4	LLY	ELI LILLY & Co	50	$59,971
5	BMY	Bristol Myers Squibb Co This page	980	$56,467
6	GSK	GSK plc	269	$14,100
7	PFE	Pfizer Inc	150	$3,612

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$56,467	980	0.0%	Shares	Sole	2026-07-27
2026-03-31	$59,437	980	+68.1%	Shares	Sole	2026-05-11
2025-12-31	$31,447	583	+0.5%	Shares	Sole	2026-01-22
2025-09-30	$26,158	580	-74.9%	Shares	Sole	2025-10-22
2025-06-30	$107,022	2,312	+298.6%	Shares	Sole	2025-08-12
2025-03-31	$35,374	580	0.0%	Shares	Sole	2025-04-16
2024-12-31	$32,804	580	0.0%	Shares	Sole	2025-01-23
2024-09-30	$30,009	580	0.0%	Shares	Sole	2024-10-22
2024-06-30	$24,087	580	0.0%	Shares	Sole	2024-07-19
2024-03-31	$31,453	580	—	Shares	Sole	2024-04-22
No filing history on record for this holder in this stock.